Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josiah D Allen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Discovery Medicine|November 16, 2013
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorderJoel G Winner, Joseph M Carhart, C Anthony Altar, et al.
Frontiers in Psychiatry|March 20, 2023
Editorial: Precision psychiatry from a pharmacogenetics perspectiveLisa C Brown, Josiah D Allen, Harris A Eyre, et al.
Journal of Personalized Medicine|November 26, 2025
Retrospective Evaluation of the Impact of <i>SLCO1B1</i> Variation on Statin EffectivenessMayeesha Ahmed Feldman, Kendall Billman, Mounia Sennoun, et al.
Pharmacotherapy|June 11, 2020
CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta-analysisLusi Zhang, Sarah Jane Brown, Yuting Shan, et al.
Journal of Personalized Medicine|September 23, 2022
Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)Josiah D Allen, Lusi Zhang, Alyssa N K Johnson, et al.
Clinical and Translational Science|August 22, 2024
Reply to "A call for reporting of tumor-specific outcomes in studies of DPYD genotyping"Nihal El Rouby, Josiah D Allen, Megan Muldoon, et al.
Current Medical Research and Opinion|June 19, 2015
Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluationJoel G Winner, Joseph M Carhart, C Anthony Altar, et al.
Pharmacogenetics and Genomics|September 11, 2013
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingDaniel K Hall-Flavin, Joel G Winner, Josiah D Allen, et al.
Frontiers in Genetics|November 8, 2021
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health SystemPawel Mroz, Stephen Michel, Josiah D Allen, et al.
Clinical and Translational Science|November 27, 2025
Multi-Gene Pharmacogenomic Testing in a Community-Based Setting Is Feasible and Reduces Total Healthcare CostsNihal El Rouby, Josiah D Allen, Tyler Koep, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Discovery Medicine|November 16, 2013
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorderJoel G Winner, Joseph M Carhart, C Anthony Altar, et al.
Frontiers in Psychiatry|March 20, 2023
Editorial: Precision psychiatry from a pharmacogenetics perspectiveLisa C Brown, Josiah D Allen, Harris A Eyre, et al.
Journal of Personalized Medicine|November 26, 2025
Retrospective Evaluation of the Impact of <i>SLCO1B1</i> Variation on Statin EffectivenessMayeesha Ahmed Feldman, Kendall Billman, Mounia Sennoun, et al.
Pharmacotherapy|June 11, 2020
CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta-analysisLusi Zhang, Sarah Jane Brown, Yuting Shan, et al.
Journal of Personalized Medicine|September 23, 2022
Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)Josiah D Allen, Lusi Zhang, Alyssa N K Johnson, et al.
Clinical and Translational Science|August 22, 2024
Reply to "A call for reporting of tumor-specific outcomes in studies of DPYD genotyping"Nihal El Rouby, Josiah D Allen, Megan Muldoon, et al.
Current Medical Research and Opinion|June 19, 2015
Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluationJoel G Winner, Joseph M Carhart, C Anthony Altar, et al.
Pharmacogenetics and Genomics|September 11, 2013
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingDaniel K Hall-Flavin, Joel G Winner, Josiah D Allen, et al.
Frontiers in Genetics|November 8, 2021
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health SystemPawel Mroz, Stephen Michel, Josiah D Allen, et al.
Clinical and Translational Science|November 27, 2025
Multi-Gene Pharmacogenomic Testing in a Community-Based Setting Is Feasible and Reduces Total Healthcare CostsNihal El Rouby, Josiah D Allen, Tyler Koep, et al.
Pageof 3